Rio Tinto to Invest $300 million in Modernising Aluminium Smelter in Canada

Rio Tinto is to invest an additional US$300 million in the modernisation of the Kitimat aluminium smelter in British Columbia, Canada, bringing the current project funding total to over US$500 million.

"The Kitimat Modernisation Project leverages two of our greatest competitive advantages - clean, self-generated hydropower and internationally renowned AP smelting technology. This investment continues construction and maintains critical paths for the project, while we seek opportunities to reduce capital costs in the currently challenging economic climate" said Dick Evans, Chief executive, Rio Tinto Alcan.

This stage of funding will secure the launch of an anode baking furnace, substation, casthouse, and construction workers' camp, as well as ancillary services.

"The Kitimat Modernisation Project remains a priority for Rio Tinto Alcan and this investment allows us to continue building on what the project team has already accomplished," said Jacynthe Côté, President and chief executive officer, Primary Metal, Rio Tinto Alcan. "We will progress with construction and driving further value from the project."

The modernisation of the Kitimat aluminium smelter will increase its current production from 245,000 tonnes per year to approximately 400,000 tonnes per year, representing growth of more than 60 per cent. Rio Tinto Alcan's proprietary AP technology is the most cost effective, energy efficient, and environmentally friendly smelting technology available, allowing the modernised plant to reduce greenhouse gas emissions by up to 40 per cent per year.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.